Mark is the president of clinical operations and commercial solutions at Labcorp Drug Development. He oversees global project delivery, clinical delivery, functional service provider, Covance market access, patient solutions, safety and data sciences. In addition, Mark supervises the global commercial organization’s enterprise client solutions, including strategic deal development, proposal, and contracts for our early development, clinical trials testing solutions, and clinical development and commercialization services. Mark joined Covance in 2017 from Quintiles, where he spent 16 years in progressive leadership positions across the enterprise, including VP of global business operations and capabilities across the clinical development organization. Mark is a North Carolina native. He attended North Carolina State University, earned a B.Sc in economics, and previously served two terms on the board of advisors for North Carolina State University College of Management.
SESSIONS
A View from the Top: How Labcorp is Leveraging CDMS and the Clinical Suite to Streamline Trial Delivery
12:30pm EDT